THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.
Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
Tenet Healthcare NYSE: THC raised its full-year 2026 financial outlook after reporting second-quarter results that exceeded its expectations, supported by hospital volume growth, higher-acuity services, expense-management efforts and continued strength in its ambulatory surgery business.
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet Healthcare (THC) came out with quarterly earnings of $6.12 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $4.02 per share a year ago.
THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $194.91, denoting a -2.15% move from the preceding trading day.
Tenet Healthcare (THC) closed the most recent trading day at $204.25, moving 1.22% from the previous trading session.
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $208.82, denoting a +1.28% move from the preceding trading day.
Tenet Healthcare Corporation THC is well-poised to grow, backed by the expanding adjusted admissions. Its solid Ambulatory Care segment performance is also a major tailwind.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.